top of page

LIVE ~ Clinical Review for Oncologists and Pharmacists - Biosimilars, 6/2/21

Updated: Jun 1, 2021


o To consider the economic burden of biologics

o To review the clinical profile of UDENYCA®, including mechanism of action, efficacy, safety, indications, and dosing o To examine the clinical development program for UDENYCA®, including key analytical, pharmacology, immunogenicity, and safety studies

o To provide an overview of patient services through Coherus COMPLETE

38 views0 comments


bottom of page